In summary, incretin receptor agonists demonstrate consistent anti-fibrotic effects in vivo , reducing hepatic stellate cell activation, oxidative stress, and collagen deposition in animal models, and improving fibrosis outcomes in clinical MASLD and MASH studies
Ambati, S
Wieschhaus A, Khan A, Zaidi A, Rogalin H, Hanada T, Liu F, et al
A 2024 pharmacokinetic modeling study (Urva et al., Clinical Pharmacokinetics ) simulated early dosing scenarios and found that dosing 48 hours early increased the risk of nausea by 42% and vomiting by 38% compared to on-schedule dosing during the overlap window
TECOS Study Group
Never Leave Charging LiPo Batteries Unattended Do not leave the room while charging your batteries